Assetmark, Inc Glaukos Corp Transaction History
Assetmark, Inc
- $41.6 Billion
- Q2 2025
A detailed history of Assetmark, Inc transactions in Glaukos Corp stock. As of the latest transaction made, Assetmark, Inc holds 16 shares of GKOS stock, worth $1,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16Holding current value
$1,375% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding GKOS
# of Institutions
329Shares Held
53.6MCall Options Held
259KPut Options Held
481K-
Black Rock Inc. New York, NY8.04MShares$691 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$525 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$279 Million0.06% of portfolio
-
State Street Corp Boston, MA2.09MShares$180 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2MShares$172 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.09B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...